JNK is activated but does not mediate hippocampal neuronal apoptosis in experimental neonatal pneumococcal meningitis

Neurobiology of Disease

Volumn 32, Issue 1, 2008, Pages 142-150

  Sury, Matthias D ^a   Agarinis, Claudia ^a   Widmer, Hans Rudolf ^a   Leib, Stephen L ^a   Christen, Stephan ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

AS601245; Bacterial meningitis; c Jun N terminal kinase; D JNKI 1; Dentate gyrus; Neuronal apoptosis

Indexed keywords

(1,3 BENZOTHIAZOL 2 YL)[2 [2 (3 PYRIDINYL)ETHYLAMINO] 4 PYRIMIDINYL]ACETONITRILE; D JNKI 1; JNK ACTIVATING KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE KINASE 7; PROTEIN C JUN; PROTEIN INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACTERIAL MENINGITIS; CELL MIGRATION; CONTROLLED STUDY; DENTATE GYRUS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; NERVE CELL; NEWBORN DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; ENZYME ACTIVATION; HIPPOCAMPUS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MENINGITIS, PNEUMOCOCCAL; MITOGEN-ACTIVATED PROTEIN KINASE 10; NEURONS; RATS; RATS, WISTAR;

EID: 51349158213     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2008.07.006     Document Type: Article

References (45)

1. Barry C.E., et al. Activation of c-Jun-N-terminal kinase is critical in mediating lipopolysaccharide-induced changes in the rat hippocampus. J. Neurochem. 93 (2005) 221-231
2. Beckham J.D., et al. Novel strategy for treatment of viral central nervous system infection by using a cell-permeating inhibitor of c-Jun N-terminal kinase. J. Virol. 81 (2007) 6984-6992
3. Benn S.C., and Woolf C.J. Adult neuron survival strategies-slamming on the brakes. Nat. Rev. Neurosci. 5 (2004) 686-700
4. Bifrare Y.D., et al. Bacterial meningitis causes two distinct forms of cellular damage in the hippocampal dentate gyrus in infant rats. Hippocampus 13 (2003) 481-488
5. Bifrare Y.D., et al. Brain-derived neurotrophic factor protects against multiple forms of brain injury in bacterial meningitis. J. Infect. Dis. 191 (2005) 40-45
6. Borsello T., et al. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat. Med. 9 (2003) 1180-1186
7. Braun J.S., et al. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat. Med. 5 (1999) 298-302
8. Brecht S., et al. Specific pathophysiological functions of JNK isoforms in the brain. Eur. J. Neurosci. 21 (2005) 363-377
9. Cao J., et al. Distinct requirements for p38alpha and c-Jun N-terminal kinase stress-activated protein kinases in different forms of apoptotic neuronal death. J. Biol. Chem. 279 (2004) 35903-35913
10. Carboni S., et al. AS601245 (1,3-benzothiazol-2-yl (2-[[2-(3-pyridinyl) ethyl] amino]-4 pyrimidinyl) acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties. J. Pharmacol. Exp. Ther. 310 (2004) 25-32
11. Carboni S., et al. Control of death receptor and mitochondrial-dependent apoptosis by c-Jun N-terminal kinase in hippocampal CA1 neurones following global transient ischaemia. J. Neurochem. 92 (2005) 1054-1060
12. Chang L., et al. JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. Dev. Cell. 4 (2003) 521-533
13. Christen S., et al. Oxidative stress in brain during experimental bacterial meningitis: differential effects of alpha-phenyl-tert-butyl nitrone and N-acetylcysteine treatment. Free. Radic. Biol. Med. 31 (2001) 754-762
14. Cumming G., et al. Error bars in experimental biology. J. Cell. Biol. 177 (2007) 7-11
15. Eilers A., et al. Direct inhibition of c-Jun N-terminal kinase in sympathetic neurones prevents c-jun promoter activation and NGF withdrawal-induced death. J. Neurochem. 76 (2001) 1439-1454
16. Eminel S., et al. c-Jun N-terminal kinases trigger both degeneration and neurite outgrowth in primary hippocampal and cortical neurons. J. Neurochem. 104 (2008) 957-969
17. Gaillard P., et al. Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase. J. Med. Chem. 48 (2005) 4596-4607
18. Gerber J., et al. Increased neurogenesis after experimental Streptococcus pneumoniae meningitis. J. Neurosci. Res. 73 (2003) 441-446
19. Gianinazzi C., et al. Caspase-3 mediates hippocampal apoptosis in pneumococcal meningitis. Acta Neuropathol. (Berl). 105 (2003) 499-507
20. Gleeson J.G., et al. Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron 23 (1999) 257-271
21. Grandgirard D., et al. Pneumococcal meningitis induces apoptosis in recently postmitotic immature neurons in the dentate gyrus of neonatal rats. Dev. Neurosci. 29 (2007) 134-142
22. Grimwood K., et al. Adverse outcomes of bacterial meningitis in school-age survivors. Pediatrics 95 (1995) 646-656
23. Jin K., et al. Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 4710-4715
24. Krawisz J.E., et al. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87 (1984) 1344-1350
25. Kuan C.Y., et al. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22 (1999) 667-676
26. Kuan C.Y., et al. A critical role of neural-specific JNK3 for ischemic apoptosis. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15184-15189
27. Leib S.L., et al. Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain 124 (2001) 1734-1742
28. Loeffler J.M., et al. The free radical scavenger alpha-phenyl-tert-butyl nitrone aggravates hippocampal apoptosis and learning deficits in experimental pneumococcal meningitis. J. Infect. Dis. 183 (2001) 247-252
29. Manning A.M., and Davis R.J. Targeting JNK for therapeutic benefit: from junk to gold?. Nat Rev. Drug Discov. 2 (2003) 554-565
30. Merkelbach S., et al. Cognitive outcome after bacterial meningitis. Acta Neurol. Scand. 102 (2000) 118-123
31. Mitchell L., et al. Dual phases of apoptosis in pneumococcal meningitis. J. Infect. Dis. 190 (2004) 2039-2046
32. Nau R., et al. Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis. J. Neuropathol. Exp. Neurol. 58 (1999) 265-274
33. Okuno S., et al. The c-Jun N-terminal protein kinase signaling pathway mediates Bax activation and subsequent neuronal apoptosis through interaction with Bim after transient focal cerebral ischemia. J. Neurosci. 24 (2004) 7879-7887
34. Papa S., et al. Linking JNK signaling to NF-kappaB: a key to survival. J. Cell. Sci. 117 (2004) 5197-5208
35. Pfister L.A., et al. Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meningitis. Ann. Neurol. 47 (2000) 329-335
36. Ren H., et al. Induction of haem oxygenase-1 causes cortical non-haem iron increase in experimental pneumococcal meningitis: evidence that concomitant ferritin up-regulation prevents iron-induced oxidative damage. J. Neurochem. 100 (2007) 532-544
37. Schaper M., et al. Cerebral vasculature is the major target of oxidative protein alterations in bacterial meningitis. J. Neuropathol. Exp. Neurol. 61 (2002) 605-613
38. Schuchat A., et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N. Engl. J. Med. 337 (1997) 970-976
39. Sury M.D., et al. Evidence that N-acetylcysteine inhibits TNF-alpha-induced cerebrovascular endothelin-1 upregulation via inhibition of mitogen-and stress-activated protein kinase. Free. Radic. Biol. Med. 41 (2006) 1372-1383
40. Waetzig V., and Herdegen T. Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage. Trends. Pharmacol. Sci. 26 (2005) 455-461
41. Wakamatsu Y., and Weston J.A. Sequential expression and role of Hu RNA-binding proteins during neurogenesis. Development 124 (1997) 3449-3460
42. Weston C.R., and Davis R.J. The JNK signal transduction pathway. Curr. Opin. Cell. Biol. 19 (2007) 142-149
43. Xia Z., et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
44. Yang D.D., et al. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389 (1997) 865-870
45. Zhuang Z.Y., et al. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J. Neurosci. 26 (2006) 3551-3560